Dr Sirpa-Liisa Hovi

Agency:

FinOHTA (MUMM)

Job Title:

Senior Researcher

Organisation:

Managed Uptake of Medical Methods programme

Tel:

+35820 610 7364

Email:

sirpa.hovi@thl.fi

Website:

www.thl.fi/HALO

Address:

National Institute for Health and Welfare, P.O. Bo, Lintulahdenkuja 4, Finland, 00271 Helsinki

Agency Member Since:

01/11/2007

Additional Contacts:

marjukka.makela@thl.fi; tuija.ikonen@thl.fi; tiina lehmussari@thl.fi

EAAS Name:

Managed Uptake of Medical Methods - programme (MUMM)

EAAS Host Organisation:

Finohta/THL

Country and/or Region:

Finland

Year EAAS formally established:

2006

EAAS Status:

Permanent

EAAS Main Output Language:

Finnish

EAAS Description:

MUMM is a joint effort of the secondary /tertiary care organizations (hospitals /hospital districts) in Finland. A board consists of one representative per hospital district (n=21), and a chair person is one of the Medical Directors. The aim of MUMM is to develop a national system to improve decision making concerning uptake of new medical technologies /methods (currently drugs are only piloted). MUMM is 100% government funded and produces outputs of 5-10 rapid reviews per year. The programme was launched in 2006. The main customers of MUMM are hospital decision makers.

Main source of funding:

National health system - Department of Health or health services

Purpose of EAAS:

• To inform decisions on captical or recurrent spending
• To inform decisions on undertaking secondary research (health technology assessments, systematic reviews)

Types of technologies covered by EAAS:

• Devices (including imaging equipment)
• Diagnostics (diagnostic and prognostic biomarkers)
• Interventional procedures (e.g. surgery)

Main customers of EAAS:

• National Government Health Departments & Ministers
• Health services purchasers, commissioners or other decision makers
• Health care providers e.g. hospitals
• Health care professionals, medical advisors or clinical experts

Contents of Main Output from EAAS:

• Safety and efficacy
• Assessment of clinical effectiveness